These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 306574

  • 1. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA.
    N Engl J Med; 1978 May 25; 298(21):1157-9. PubMed ID: 306574
    [Abstract] [Full Text] [Related]

  • 2. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM, Drayer DE.
    Angiology; 1986 Dec 25; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [Abstract] [Full Text] [Related]

  • 3. Antinuclear antibodies related to acetylator phenotype in mice.
    Tannen RH, Weber WW.
    J Pharmacol Exp Ther; 1980 Jun 25; 213(3):485-90. PubMed ID: 6970809
    [Abstract] [Full Text] [Related]

  • 4. Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide.
    Sonnhag C, Karlsson E, Hed J.
    Acta Med Scand; 1979 Jun 25; 206(4):245-51. PubMed ID: 92167
    [Abstract] [Full Text] [Related]

  • 5. Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide.
    Mongey AB, Sim E, Risch A, Hess E.
    J Rheumatol; 1999 Aug 25; 26(8):1721-6. PubMed ID: 10451068
    [Abstract] [Full Text] [Related]

  • 6. Thrombocytopenia following sustained-release procainamide.
    Meisner DJ, Carlson RJ, Gottlieb AJ.
    Arch Intern Med; 1985 Apr 25; 145(4):700-2. PubMed ID: 2580499
    [Abstract] [Full Text] [Related]

  • 7. In vitro production of antibodies to histones in patients receiving chronic procainamide therapy.
    Mongey AB, Hess E.
    J Rheumatol; 2001 Sep 25; 28(9):1992-8. PubMed ID: 11550965
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-term treatment with procaine amide. A prospective study with special regard to ANF and SLE in fast and slow acetylators.
    Henningsen NC, Cederberg A, Hanson A, Johansson BW.
    Acta Med Scand; 1975 Dec 25; 198(6):475-82. PubMed ID: 55060
    [Abstract] [Full Text] [Related]

  • 9. The implications of procainamide metabolism to its induction of lupus.
    Uetrecht JP, Freeman RW, Woosley RL.
    Arthritis Rheum; 1981 Aug 25; 24(8):994-1003. PubMed ID: 6169352
    [Abstract] [Full Text] [Related]

  • 10. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus.
    Totoritis MC, Tan EM, McNally EM, Rubin RL.
    N Engl J Med; 1988 Jun 02; 318(22):1431-6. PubMed ID: 3259287
    [Abstract] [Full Text] [Related]

  • 11. Drug-induced systemic lupus erythematosus.
    Weinstein A.
    Prog Clin Immunol; 1980 Jun 02; 4():1-21. PubMed ID: 6992215
    [Abstract] [Full Text] [Related]

  • 12. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
    Dixon JA, Mulhern LM, Whiteside TL, Luksick J.
    J Rheumatol; 1980 Jun 02; 7(4):544-6. PubMed ID: 6999152
    [Abstract] [Full Text] [Related]

  • 13. SLE: idiopathic or drug-induced?
    Condemi JJ.
    Geriatrics; 1980 Mar 02; 35(3):81-8. PubMed ID: 6965485
    [Abstract] [Full Text] [Related]

  • 14. Antinuclear antibody induced by procainamide. A prospective study.
    Blomgren SE, Condemi JJ, Bignall MC, Vaughan JH.
    N Engl J Med; 1969 Jul 10; 281(2):64-6. PubMed ID: 4182059
    [No Abstract] [Full Text] [Related]

  • 15. Clinical consequences of polymorphic acetylation of basic drugs.
    Drayer DE, Reidenberg MM.
    Clin Pharmacol Ther; 1977 Sep 10; 22(3):251-8. PubMed ID: 19187
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of discoid lupus erythematosus with sulfasalazine: 11 cases].
    Delaporte E, Catteau B, Sabbagh N, Gosselin P, Breuillard F, Doutre MS, Broly F, Piette F, Bergoend H.
    Ann Dermatol Venereol; 1997 Sep 10; 124(2):151-6. PubMed ID: 9740825
    [Abstract] [Full Text] [Related]

  • 17. [Lupus erythematosus syndrome in the course of procainamide treatment].
    Dabrowska B, Lapińska K, Blaszczyk M.
    Kardiol Pol; 1971 Sep 10; 14(3):316-20. PubMed ID: 5316267
    [No Abstract] [Full Text] [Related]

  • 18. Autoallergic reactions induced by procainamide.
    Tan EM, Rubin RL.
    J Allergy Clin Immunol; 1984 Oct 10; 74(4 Pt 2):631-4. PubMed ID: 6386937
    [Abstract] [Full Text] [Related]

  • 19. [Lupus erythematosus in the course of treatment with procaine amide: report of a case].
    Dabrowska B, Lapińska K, Blaszczyk M.
    Kardiol Pol; 1971 Oct 10; 14(3):317-20. PubMed ID: 5315756
    [No Abstract] [Full Text] [Related]

  • 20. [Procainamide-induced lupus erythematosus].
    Seligmann H, Potasman I, Bassan H.
    Harefuah; 1980 Oct 01; 99(7):166-9. PubMed ID: 6970709
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.